Exactly! Cancer and stem cell therapeutics quietly making progress. Will go main stream in a few years.
Today as you know one of our regen devices received first round FDA approval. Next up AST and UCLA to announce stroke regen therapy to start clinical trials.
-Nano-peptide cancer diagnostics....nothing on the market, competitors Merck, J&J
-Stem cell/ECM regen therapies....nothing on the market, competitors all behind.
BTX clear leader in the world with 800+stem patents